Efficacy and Safety of CVT-E002, a Proprietary Extract of Panax quinquefolius in the Prevention of Respiratory Infections in Influenza-Vaccinated Community-Dwelling Adults: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial

CVT-E002 (a proprietary extract) was found to be effective in the prevention of upper respiratory infections (URIs) in healthy adults, and institutionalized and community-dwelling seniors. A multicenter, randomized, double-blind, placebo-controlled trial was carried out to determine effects of CVT-E...

Descripción completa

Detalles Bibliográficos
Autores principales: McElhaney, Janet E., Simor, Andrew E., McNeil, Shelly, Predy, Gerald N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447298/
https://www.ncbi.nlm.nih.gov/pubmed/23074661
http://dx.doi.org/10.1155/2011/759051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447298/
https://www.ncbi.nlm.nih.gov/pubmed/23074661
http://dx.doi.org/10.1155/2011/759051

Ejemplares similares